• JoinedOctober 17, 2023

Stories by Jenny zou
  • 3 Published Stories
Medicilon Assists Longsee Biomedical's LF01 capsules approved for clinical use by Medicilon
Medicilon Assists Longsee Biomedic...
On November 20, LF01, an innovative anti-tumor drug independently developed by Longsee Biomedical Co. Ltd. (L...
Medicilon Assists YY201 successfully completed dual submissions in China and US by Medicilon
Medicilon Assists YY201 successful...
Recently, YY201, a STAT3 dual phosphorylation site inhibitor independently developed by Yuyao Biotech, was ap...
Medicilon Assists Huaota's CD73-targeting ADC approved for clinical use in US by Medicilon
Medicilon Assists Huaota's CD73-ta...
Recently, Shanghai Huaota Biopharmaceutical Co., Ltd. (Huaota) received a notification from the US FDA, agree...
ranking #123 in adc See all rankings